Translate
Text Highlighter

Bookmark

PDF

Share

Report a problem
AMICUS AI
Citation Codes
Equivalent Citations
citation codes
Case Number
Judges
Acts
  • SECTION 2 A MONOPOLIES AND RESTRICTIVE TRADE PRACTICES ACT 1969
  • clause (41) of Section 2 of the Companies Act, 1956 (1 of 1956).9.Section 4(1)(b)
  • provisions of Section 4 read with Rules 5 and 7 of Valuation Rules
  • clause (c) of sub-section (4) of Section 4 of the amended Act.
  • CENTRAL EXCISE ACT 1944
  • provisions of Section 285 of the Companies Act, 1965, M/s.
  • Rule 5 of the Central Excise Valuation Rules
  • Section 4(3)(b)(iv). Clause (b) of sub-section (3)
  • clause (c) of sub-section (4) of Section 4
  • DRUGS AND COSMETICS ACT
  • sub-section (1) of Section 4.10.The
  • SECTION 159 COMPANIES ACT 1956
  • Companies Act, 1956 (1 of 1956).(b)
  • Central Excise Tariff Act, 1985
  • Section 4(1)(b) of Section 4(1)
  • Rule 8.RULE 10
Are you a practicing lawyer?
Enhance your digital presence and reach by creating a Casemine profile.
Upload pleading to use the new AI search
Cites
Cited by
Citation Codes
Equivalent Citations
citation codes
Case Number
Judges
Acts
  • SECTION 2 A MONOPOLIES AND RESTRICTIVE TRADE PRACTICES ACT 1969
  • clause (41) of Section 2 of the Companies Act, 1956 (1 of 1956).9.Section 4(1)(b)
  • provisions of Section 4 read with Rules 5 and 7 of Valuation Rules
  • clause (c) of sub-section (4) of Section 4 of the amended Act.
  • CENTRAL EXCISE ACT 1944
  • provisions of Section 285 of the Companies Act, 1965, M/s.
  • Rule 5 of the Central Excise Valuation Rules
  • Section 4(3)(b)(iv). Clause (b) of sub-section (3)
  • clause (c) of sub-section (4) of Section 4
  • DRUGS AND COSMETICS ACT
  • sub-section (1) of Section 4.10.The
  • SECTION 159 COMPANIES ACT 1956
  • Companies Act, 1956 (1 of 1956).(b)
  • Central Excise Tariff Act, 1985
  • Section 4(1)(b) of Section 4(1)
  • Rule 8.RULE 10
Smart Summary

Structured Summary of the Opinion

Factual and Procedural Background

This appeal was filed by M/s. Transasia Bio-Medicals Ltd. (TBM), Shri Vijay Parikh, Shri Suresh Vazirani and Shri S.R. Malhotra against Order No. 03/MP/DAMAN/2007 dated 28-02-2007 of the Commissioner of Central Excise & Customs, Daman. The adjudicating authority had demanded duties and imposed penalties on TBM on several counts: alleged gross undervaluation of a product called "Cell Pack" (duty demanded Rs. 1,79,02,993), clandestine clearances of diagnostic reagents and demo kits under the guise of free replenishment (duty demanded Rs. 44,72,100), collection of handling and forwarding charges without paying duty (duty demanded Rs. 22,79,869), and alleged wrongful claim of SSI exemption for exceeding Rs. 3 crores in the relevant year (duty demanded Rs. 15,09,963). The appellants appealed the adjudicating authority's order. The file contains detailed factual material, documentary evidence submitted by the appellants, and extensive discussion by the Tribunal of valuation law, related‑person tests, and the evidentiary burden on Revenue.

Legal Issues Presented

  1. Whether M/s. Sysmex Transasia Bio-Medicals Ltd. (M/s. STBM) is a "dummy" unit and, relatedly, whether a show cause notice ought to have been issued to M/s. STBM.
  2. Whether the Cell Packs were actually transported to M/s. STBM's premises and what the correct assessable value of those Cell Packs should be (i.e., appropriate valuation principle under Section 4 and the Valuation Rules).
  3. Whether diagnostic reagents (including Cell Packs) are exempt from excise duty on the basis that they are meant for use only with auto analyzers which were exempt under Notification No. 6/2003‑C.E.
  4. Whether provisions of Rule 4 read with Rules 5 and 7 of the Central Excise Valuation Rules, or alternatively Rules 8–10, are applicable; specifically whether transportation/packing/forwarding charges are includable in assessable value.
  5. Whether SSI exemption for the relevant year was correctly disallowed by the Revenue (i.e., whether clearances in the previous year exceeded the prescribed limit when valued correctly).
  6. Whether extended period of limitation and penalties (under Section 11AC and interest under Section 11AB) were justified on the basis of suppression or misstatement with intent to evade duty.

Arguments of the Parties

Appellants' Arguments

  • TBM contended that M/s. STBM was an independent joint‑venture company (49% TBM, 51% foreign partner) created by formal agreements, registration, annual returns, income‑tax acknowledgements and other corporate records showing independent existence and corporate formalities (joint venture agreement, memorandum & articles, annual returns, board minutes, RBI communications, loan licence under Drugs & Cosmetics Act etc.).
  • TBM maintained that the Cell Pack manufacture was carried out on a bona fide job‑work basis under a manufacturing/job‑work arrangement: STBM imported raw material under proper customs clearance and loan licence, supplied raw materials to TBM for job work, and TBM reimbursed costs and job charges by debit notes; duty was paid on the basis of the selling price (Rs. 850 per unit) charged by STBM, consistent with the Ujagar Prints principle that cost + manufacturing profit is a correct basis of valuation when applicable.
  • TBM submitted transport receipts, excise invoices and records to show movement and accounting; argued that physical movement to STBM premises was not necessary as a legal obligation but a business choice; asserted compliance with record keeping and regular audits.
  • On diagnostic reagents and demo kits, TBM argued these were supplied as part of the instrument sale (auto analyzers exempt under Notification No. 6/2003) as free replenishments or discounts in kind, or as non‑marketable demo kits whose cost was included in the exempt instrument's sale price; thus no separate duty was payable on such supplies.
  • On freight/packing & forwarding, TBM contended that where goods are sold at factory gate and delivered from a depot, transaction value excludes transportation from place of removal to place of delivery; they sought deduction of actual freight from depot to customer premises in line with Rule 5.
  • On SSI exemption and extended period/penalties, TBM asserted there was no suppression or misstatement with intent to evade duty, records were maintained and available for audit, and that the department was aware of the activities — hence penalties and extended period were not sustainable.

Revenue's Arguments

  • Revenue alleged M/s. STBM was a paper/dummy company created to show job‑work clearances at a low price (Rs. 850 per pack) so as to undervalue and evade duty; STBM was not registered with Sales Tax at Daman, had no employees on its payroll, and did not receive or possess the goods at its declared premises.
  • Revenue asserted physical movement did not occur to STBM's premises and that TBM cleared goods directly from its factory to its godown in Mumbai or to ultimate customers; therefore the transaction value needed to be determined with reference to related‑person rules (Section 4(3)(b)(iv)) and Valuation Rules (they wanted valuation under Rule 8 or Rules 8–10 rather than simple transaction value).
  • Revenue contended that diagnostic reagents supplied free or as demo kits were in reality clearances without payment of duty and needed to be treated as taxable clearances; similarly, they alleged excessive handling & forwarding charges were used to suppress assessable value.
  • Revenue maintained that SSI exemption was incorrectly availed for the year 2001–02 because TBM's clearances for the previous year actually exceeded Rs. 3 crores when correctly valued.
  • Revenue claimed extended period was justified and penalties/interest were warranted on grounds of suppression/misstatement with intent to evade duty.

Table of Precedents Cited

Precedent Rule or Principle Cited For Application by the Court
Pye v. Minister for Lands for NSW (1954) 3 All ER 514 Interpretative principle: prefer a construction that achieves the manifest purpose of legislation and avoids reducing it to futility (quoted via Viscount Simon). The opinion cites the passage as an overarching interpretative guide in construing statutory provisions.
M Pentiah v. Veeramallappa Muddala (1961) 2 SCR 295 This citation appears among listed authorities; the opinion does not specify the exact principle invoked from this case in the text. The case is cited in the list of authorities at the outset; the opinion does not articulate a specific application elsewhere in the text provided.
Union of India v. Sankalchand AIR 1977 SC 2328; (1977) 4 SCC 193 Cited among initial authorities; the opinion does not state the precise principle from this case in the body of the extract. Listed among authorities at the start; no discrete application is described in the passages reproduced.
Superintendent & Remembrancer v. Abani Maity AIR 1979 SC 1029; (1977) 4 SCC 85 Cited among authorities; specific rule/principle not explicated in the opinion extract. Cited in the prefatory list of authorities; no separate application is detailed in the excerpt.
Mohan Kumar Singhania v. Union of India AIR 1992 SC 1; 1992 Supp (1) SCC 594 Cited among initial authorities; the specific principle used in the present decision is not specified in the text. Included in the list of cases referred to at the outset; the opinion does not state an explicit application in this excerpt.
Commissioner of Income Tax v. Hindustan Bulk Carriers Referenced (as “supra”); the opinion does not set out the rule/principle quoted from this authority in the provided text. Cited among the authorities in the opening paragraph; no explicit application described in the reproduced text.
Balram Kumawat v. Union of India (2003) 7 SCC 628 Cited among authorities; the excerpt does not specify the principle taken from this case. Listed in the prefatory authorities; no express use is detailed later in the opinion excerpt.
Union of India & Ors. v. Atic Industries Ltd. (Supreme Court) Principle on the definition of "related person" under Section 4: requires reciprocity of interest — each party must have some interest, direct or indirect, in the business of the other. The Tribunal expressly follows and applies the Atic Industries reasoning to find that mere one‑sided interest is insufficient to qualify parties as "related" under the statutory definition; this reasoning was central to rejecting Revenue's related‑person valuation approach in the present case.
Commissioner of Customs, Kolkata v. Initiating Explosives System (I) Ltd. (S.C.) Principle that the burden to prove undervaluation lies on the Revenue. Cited to support the conclusion that Revenue failed to discharge the burden of proving undervaluation in this matter.
Ujagar / Ujjagar Prints case (Supreme Court authority invoked) Principle regarding valuation in job‑work situations: value/duty to be paid on cost of raw material + cost of manufacture + manufacturing profit (as applied in job‑work contexts). The appellants relied on this principle in explaining payment of duty and valuation when job work is involved; the Tribunal references the principle in evaluating valuation submissions.
Thiagraja Engineering Enterprise v. CCE (S.C.) Cited by the appellant in support of their position regarding job‑work/related entities; the opinion excerpt does not state the exact rule relied upon. Included in the list of cases relied upon by appellant counsel to demonstrate precedential support for their factual/contention of independent existence or accounting practice; no discrete application is elaborated in the excerpt.
Industrial Supplies and Services v. CCE (Tri.-Del.) Cited by appellants as supporting authorities; the opinion excerpt does not identify a specific principle from this case. Listed among the appellate decisions relied upon by appellants; no separate application is detailed in the provided text.
Box and Carton India (P) Ltd. v. CCE (Tri.-Del.) Cited by appellants as a supporting decision; the excerpt does not state the precise principle invoked. Referenced by appellant counsel as precedent; the opinion does not specify a direct application in the excerpt.
Baroda Electric Meter (Supreme Court) Addressed the question of whether transportation/freight should be included in assessable value; cited as relevant to deduction of actual freight. The Tribunal refers to Baroda Electric Meter as relevant authority supporting the deduction of actual freight from depot to customer in appropriate circumstances.
Pushpam Pharmaceuticals Co. v. CCE (Bombay / S.C.) Invoked by the appellants in the context of penalties/extended period and bona fides; the excerpt does not extract a specific doctrinal point. Listed among precedents relied upon by appellants to contest imposition of penalties/extended period; no detailed application is recorded in the excerpt.
Cosmic Dye Chemical v. CCE (Bombay / S.C.) Cited by appellants in support of their contention regarding penalty/extended period; specific principle not set out in the excerpt. Included in the appellants' list of supporting authorities on penalties and reliance on records/audit; no further application is elaborated in the provided text.
Collector v. Chemphar Drugs & Liniments (S.C.) Listed by the appellants among authorities relevant to penalties/intent; the excerpt does not state the exact rule taken from this case. Mentioned by the appellants; the Tribunal records the reliance but does not set out a discrete application in the excerpt.
Padmini Products v. Collector (S.C.) Cited by appellants with respect to penalties/extended period issues; specific principle not specified in the excerpt. Appears in the appellants' list of supporting cases; no separate application is articulated in the reproduced text.
ATE Enterprises Ltd. v. CCE (Tri.-Del.) Invoked by appellants in support of their positions on penalties and valuation issues; principle not explicitly stated in the excerpt. Referenced among supporting tribunal decisions cited by appellants; no explicit application described in the excerpt.
MEK Slotted Angles (India) Ltd. v. CCE (Tri.-Mum.) Listed by appellants in support of arguments on penalties/extended period; the excerpt does not explain the principle taken. Cited by appellants; the opinion does not reproduce an explicit application in the provided text.

Court's Reasoning and Analysis

The Tribunal undertook a focused, evidence‑based assessment rather than adopting a mechanistic approach to precedents. The analysis proceeded in the following steps (reflecting the sequence in the opinion):

  1. Preliminary statutory framework: The Tribunal identified that valuation for the purposes of charging excise duty is governed by Section 4 of the Central Excise Act, 1944, and that Section 4(1)(b) — "in any other case" — and the Central Excise Valuation Rules (particularly Rules 8–10 and Rules 4–7) were relevant to decide the appropriate valuation method in this dispute. The Tribunal noted that Revenue contended the parties were "related" per Section 4(3)(b)(iv), which would affect valuation.
  2. Assessment of whether M/s. STBM was a dummy unit: The Tribunal examined documentary materials submitted by appellants — joint venture and business centre agreements, memorandum & articles, incorporation certificate, annual returns, income‑tax acknowledgements, board minutes, RBI communications, loan licence under Drugs & Cosmetics Act and transport receipts/excise invoices — and observed that these documents were genuine and unchallenged on record. The Tribunal noted that the adjudicating Commissioner had characterized STBM as a dummy because (i) it had no employees on payroll and (ii) many of its administrative functions were handled by TBM employees, and that goods allegedly did not reach STBM premises. The Tribunal considered these factual points but concluded, based on the documentary evidence and the absence of contradiction in adjudication, that STBM could not be deemed a dummy company in the sense alleged by Revenue.
  3. Application of the "related person" test: The Tribunal relied on the Supreme Court's exposition in Union of India v. Atic Industries Ltd. to explain the statutory meaning of "related person": reciprocity of interest is required — both parties must have an interest (direct or indirect) in the business of the other. Applying that test and other authorities (including the observation that burden to prove undervaluation lies on Revenue as noted in Commissioner of Customs, Kolkata v. Initiating Explosives System (I) Ltd.), the Tribunal concluded that Revenue had failed to discharge the burden of proving that TBM and STBM were related in the statutory sense to justify valuation by reference to alleged downstream prices.
  4. On physical movement and documentation: The Tribunal noted that there was nothing on record to show that Cell Packs manufactured for STBM were not dispatched to the declared premises; appellants produced transport receipts and excise invoices and had incurred transportation charges. The Tribunal accepted that physical movement to and from STBM premises was not a legal necessity in every business arrangement and could be a commercial choice; hence absence of a particular physical handling practice did not automatically render STBM a sham.
  5. Diagnostic reagents and demo kits: The Tribunal accepted appellants' contention that diagnostic reagents supplied in connection with exempt auto analyzers (sold by TBM and exempt under Notification No. 6/2003‑C.E.) were supplied as free replenishments or discounts in kind, and that demo kits were non‑marketable items supplied for demonstration and their cost was included in the sale price of the exempt instrument. In the absence of evidence to the contrary from Revenue, the Tribunal found the appellants' position acceptable.
  6. Packing, forwarding and transportation charges: The Tribunal referred to the valuation rules (specifically Rule 5) and to the Supreme Court decision in Baroda Electric Meter to note that when goods are sold in circumstances covered by clause (a) of Section 4(1), transaction value may exclude transportation costs from place of removal to place of delivery; Revenue had admitted appellants were eligible for deduction of actual freight from their godown to customer premises. The Tribunal accepted that actual freight was deductible in the circumstances.
  7. SSI exemption, extended period and penalties: The Tribunal examined the Revenue's assertions that clearances exceeded Rs. 3 crores (affecting SSI exemption) and allegations of suppression/misstatement. Concluding that Revenue had not produced sufficient evidence to displace the appellants' recorded values, and finding no evidence of suppression with intent to evade duty, the Tribunal held that SSI exemption stood and that imposition of penalty and interest (under Sections 11AC and 11AB) was not sustainable on the record.
  8. Approach to precedent and facts: The Tribunal reiterated that precedents guide but do not decide a case mechanically — each case must be resolved on its own facts and merits. It expressly applied Atic Industries and other authority on the related‑person test, and relied on the well‑settled allocation of evidentiary burden on Revenue for undervaluation claims.

Holding and Implications

Core Ruling: The Tribunal allowed the appeals filed by M/s. Transasia Bio‑Medicals Ltd. and others and SET ASIDE the order of the Commissioner of Central Excise & Customs, Daman (Order No. 03/MP/DAMAN/2007 dated 28‑02‑2007).

Implications:

  • The adjudicating authority's determinations — including demands for the several heads of duty and the imposition of penalties and interest — were reversed insofar as they formed part of the set‑aside order. (The opinion concludes by allowing the appeals and setting aside the Commissioner’s order.)
  • The Tribunal's reasoning turned primarily on documentary evidence, absence of proof by Revenue on undervaluation and related‑person status, acceptance of the appellants' explanations on diagnostic reagents/demo kits and on freight treatment, and the finding that there was no suppression/misstatement warranting extended period/penalty.
  • No broad new legal precedent was proclaimed; the Tribunal followed and applied existing Supreme Court authority (notably Atic Industries on the "related person" test and related authorities) and emphasized deciding the case on its specific facts and evidence rather than by mechanical reliance on precedents.

(Pronounced in Court on 17-01-2012)

    Transasia Bio-Medicals Ltd. v. Commissioner of C. Ex., Daman

    [Order per : P. Babu, Member (T)]. -

    “If the choice is between two interpretations”, stated VISCOUNT SIMON, L.C., ‘the narrower of which would fail to achieve the manifest purpose of the legislation we should avoid a construction which would reduce the legislation to futility, and should rather accept the holder construction, based on the view that Parliament would legislate only for the purpose of bringing about an effective result’. [Pye v. Minister for Lands for NSW. (1954) 3 All ER 514, p.524 (PC) : M Pentiah v. Veeramallappa Muddala pp. 1110, 1111 : (1961) 2 SCR 295 : Union of India v. Sankalchand AIR 1977 S.C. 2328. p 2381 : (1977) 4 SCC 193 : 1977 SCC (Lab) 435 : Superintendent and Remembrancer LAWB v. Abani Maity. AIR 1979 SC 1029, p 1033 : (1977) 4 SCC 85 : 1979 SCC (Cri) 902 : Mohan Kumar Singhania v. Union of Inida. AIR 1992 SC 1, p. 19 : 1992 Supp (a) SCC 594 : Commissioner of Income Tax v. Hindustan Bulk Carriers, (supra), p. 74 See further Balram Kumawat v. Union of India (2003) 7 SCC 628 pp. 636, 637 : AIR 2003 SC 3268 pp. 3273, 3274.

    2. This is an appeal filed by M/s. Transasia Bio-Medicals Ltd., Shri Vijay Parikh, Shri Suresh Vazirani and Shri S.R. Malhotra against the order of Commissioner of Central Excise & Customs, Daman (Order No. 03/MP/DAMAN/2007, dated 28-2-2007).

    3. The brief facts of the case are that M/s. Transasia Bio-Medicals Ltd. (TBM) were manufacturing and selling Cell Pack to the customers but it has alleged that they devised a new modus operande and a company called M/s. Sysmex Transasia Bio-Medicals Ltd. (M/s. STBM) was created to show that M/s. TBM manufactured goods on job work basis for M/s. STBM. These goods were shown to have been cleared to M/s. STBM @ Rs. 850/- per pack which was subsequently sold to the trading arm of M/s. TBM @ Rs. 850/- per pack. Subsequently, these goods were sold to independent customers @ 1,800/- to Rs. 2,400/- per pack. The Revenue alleged that the goods never moved to the declared premises of M/s. STBM and were cleared directly from the factory of M/s. TBM either to the godown in Mumbai or to some ultimate customers. It was further alleged that M/s. STBM was created with the sole purpose of evading payment of duty by way of gross undervaluation. Duty of Rs. 1,79,02,993/- was demanded for undervaluation of Cell Pack. M/s. TBM were clearing other excisable goods namely diagnostic reagents clandestinely under the guise of free replenishment without replying the same in the production records without central excise invoices. Duty on this score will come to Rs. 44,72,100/-. Further, they were collected a part of the price of the name of handling and forwarding charges and without paying any duty on them. On this count duty of Rs. 22,79,869/- has been demanded. They were availing SSI exemption but on the basis of calculation of actual value for the year 2001-2002 they had exceeded Rs. 3 crores. The duty demanded on this count is Rs. 15,09,963/-. The adjudicating authority confirmed the entire duty involved and imposed penalties on M/s. TBM under Rule 173Q under Section 11AC of the Act. Personal penalties were also imposed. The appellants filed appeal against this order and these proceedings were initiated.

    4. However, on filing the appeal the appellants strongly contended the decision and filed three sets of paper books dated 28-5-2011. The contentions of the appellants are briefly enumerated as follows :

    5.1 The products, diagnostics reagents also include a product known as Cell Pack which is a diluent and used as an essential constituent of the instrument viz. Cell counter for blood testing. Cell Pack is connected to cell counter and the required quantity is thereafter drawn automatically which is mixed with blood samples before the blood test i.e. CBC is done. The product viz., auto analyzer is classifiable under the sub-heading No. 9027.00 of Chapter 90 of the First Schedule of the Central Excise Tariff Act, 1985 and exempted from payment of whole of the excise duty leviable thereon vide Notification No. 6/2003-C.E., dated 1-3-2003 as amended. On the other hand, the product viz., diagnostics reagents (including Cell Packs) is classifiable to duty at tariff rate as in force, from time to time.

    5.2 It was stated that M/s. TBM were clearing the product auto analyzer at nil rate of duty under Notification No. 6/2003-C.E. and the product namely diagnostics reagents on the payment of duty during the relevant period.

    M/s. TBM were having three units situated at the following premises :

    47/6, Gelwad Falia, Dabhel, Nani Daman (Unit No. 1)

    B-11, OIDC, Ringanwada, Daman (Unit No. 2) and

    SDF-VI, Unit No. 161/162, SEEPZ, Andheri (East), Mumbai-96.

    M/s. TBM carry on the manufacture of diagnostics reagents at Unit No. 1 and of auto analyzers at Unit No. 2 and also at their unit at SEEPZ. M/s. TBM also carry on trading of diagnostics reagents and auto anailyzers from Unit No. 1.

    5.3 There was common independent company known as M/s. Sysmex Transasia Bio-Medicals Ltd. found vide a joint agreement dated 31-3-1998 which entered into an agreement between M/s. Toya Medical Electronics Co. Ltd., Japan with the farmer holding 51% shares and the balance 49% of equity being held by M/s. TBM.

    5.3.1 M/s. Sysmex Transasia Bio-Medicals Ltd. was desirous of taking such limited licence with respect to the business centre development by M/s. TBM and both parties entered into a business centre agreement, dated 23-7-1998 by which a limited licence was granted by M/s. TBM to M/s. Sysmex Transasia for the use of the said business centre on payment of licence fee of Rs. 60,000/- per month and a refundable/interest free licence deposit of Rs. 3,00,000/- to be made by M/s. Sysmex Transasia.

    5.3.2 As per the arrangement, M/s. Sysmex Transasia Bio-Medicals Ltd. would import the basic raw material namely Cell Pack SB from M/s. Sysmex Corporation, Japan or Singapore and supply for purpose of manufacture of Cell Pack on job work basis and M/s. TBM in turn would procure the requisite raw materials like certain chemicals, processed (Reverse-Osmosis and Demineralised) water and packing materials such as cubitainers, cartons, etc., the cost of which would be reimbursed by M/s. Sysmex Transasia along with the job charges as agreed from time to time. For the purpose of manufacture of Cell Pack on job work basis by M/s. TBM, M/s. Sysmex Transasia also applied for and obtained the loan licence (No. DD/1/162) issued by the Drugs Licensing Authorities, Daman as required under the provisions of the Drugs & Cosmetics Act, 1940.

    5.3.3 It was stated that though M/s. TBM and M/s. Sysmex Transasia are independent legal entities and the manufacture on job work basis was done by M/s. TBM on principal to principal basis and the duty was required to be paid on the basis of cost of manufacture plus manufacturing profit in light of the principles of law laid down by the Hon’ble Supreme Court in Ujjagar Prints case, M/s. TBM were, in good faith, paying the duty on the basis of the selling price i.e. Rs. 850/- per unit charged by M/s. Sysmex Transasia accordingly. A separate commercial invoice was, however, being raised by M/s. TBM on M/s. Sysmex Transasia for the recovery of the job charges including cost of raw material/packing material used by them.

    5.3.4 M/s. Sysmex Transasia, in turn, were selling the Cell Pack to M/s. TBM at the price of Rs. 850/- per unit under the cover of commercial invoice and as per the instruction of M/s. TBM, preparing the dispatch note in the name of M/s. TBM with the address of their godown situated at Mira Road being mentioned therein as the goods were intended to be taken there for onward dispatch. M/s. TBM were ultimately selling the goods from the said godown at the prices ranging from Rs. 2,100/- per unit to Rs. 3,100/- per unit. It was argued that in view of the above arrangement, the physical movement of Cell Pack by M/s. TBM and M/s. Sysmex Transasia Bio-Medicals Ltd. it was never envisaged nor considered necessary that the same was obligatory. They were filing regularly the monthly returns and maintaining the various records as required and prescribed under the law. Such records filed by M/s. TBM were also verified, assessed or audited by the department from time to time.

    6.1 The Revenue strongly contested the points raised by the assessee. Shri S.K. Mall, learned SDR appearing on behalf of Revenue stated that a company M/s. Sysmex Transasia Bio-Medicals Ltd. was created on paper to show that M/s. TBM manufactured goods on job work basis for M/s. STBM. The goods manufactured by M/s. TBM were shown on paper to have been cleared to M/s. STBM @ Rs. 850/- per pack which subsequently sold the same to the trading arm of M/s. TBM @ Rs. 850/- per pack. M/s. STBM, Daman have shown sale of Cell Packs to M/s. TBM but M/s. STBM was not registered with Sales Tax at Daman. The goods were subsequently sold by M/s. TBM to independent customers at the rate of Rs. l800/- to Rs. 2400/- per pack. There was huge difference between the rate at which duty was paid by M/s. TBM and the rate at which the goods were finally sold by M/s. TBM. The investigations revealed that the goods never moved to the declared premises of M/s. STBM. The same were cleared directly from the factory of M/s. TBM, either to the godown of M/s. TBM in Mumbai or to the ultimate customers. It was also found that there were no employees on the rolls of M/s. STBM to take care of its activities. The employees of M/s. TBM only were maintaining the records of M/s. STBM to show that it existed. Thus, M/s. STBM was created with the sole purpose of evading payment of duty by way of gross undervaluation. Duty to the tune of Rs. 1,79,02,993/- has been demanded for undervaluation of Cell Packs.

    6.2 M/s. TBM cleared certain excisable goods viz. diagnostics reagents clandestinely, under the guise of free replenishment, and demo kits without reflecting the same in the production records and without preparing central excise invoices. Duty of Rs. 44,72,100/- has been demanded on this count. M/s. TBM also collected a part of the price in the name of “handling and forwarding” charges and did not pay duty on the same. In fact, it was found that they were actually incurring a far lower amount on transportation. Thus, they were actually suppressing the assessable value in the guise of exorbitant “handling and forwarding” charges in order to evade payment of duty. Duty of Rs. 22,79,869/- has been demanded on such excess collections.

    6.3 M/s. TBM had also availed SSI exemption on their clearances for the year 2001-2002 even though the actual value of the clearances of their excisable goods during the previous year had far exceeded Rs. 3 crores. It was also alleged that though they had not paid duty on account of exemption, they had collected the same from their customers. Hence, they were required to deposit the same with the Government as per provisions of Section 11D of Central Excise Act, 1944. Duty of Rs. 16,09,963/- has been demanded on this count.

    7.1 We have gone into details of the case carefully. The issues before us are summarized as follows :

    7.2 Whether M/s. STBM is a dummy unit or not and why a show cause notice has not been issued to them?

    7.3 Whether the Cell Packs were actually transported to M/s. STBM, Daman and what was the value to be arrived at?

    7.4 Whether the contention of the appellant that the diagnostics reagents were meant for use only with auto analyzers which were exempt from payment of duty?

    7.5 Whether the provisions of Rule 4 of the Act read with Rule 5 and Rule 7 of the Central Excise Valuation Rules of 2000 would be applicable or assuming the sale of the goods taking place at the factory gate only and the transportation charges in any nature would be includable in the assessable value?

    8. We have considered the rival submissions carefully. According to the Revenue the assessee are related in terms of Section 4(3)(b)(j)(iv) of the Act and therefore the valuation has to be done in terms of Section 4(1)(b) of Section 4(1) which reads as under :

    “Section 4 : Valuation of excisable goods for purposes of charging of duty of excise. - (1) Where under this Act, the duty of excise is chargeable on any excisable goods with reference to their value, then, on each removal of the goods, such value shall -
    (a)     in a case where the goods are sold by the assessee, for delivery at the time and place of the removal, the assessee and the buyer of the goods are not related and the price is the sole consideration for the sale, be the transaction value.
    (b)     in any other case, including the case where the goods are not sold, be the value determined in such manner as may be prescribed.”

    We also consider the Revenue’s allegation that the assessees are related in terms of Section 4(3)(b)(iv). Clause (b) of sub-section (3) reads as under :

    (3) For the purpose of this section, -
    (a)     ……………….
    (b)     Persons shall be deemed to be “related” if -
    (i)      they are inter-connected undertakings;
    (ii)     they are relatives;
    (iii)    amongst them the buyer is a relative and a distributor of the assessee, or a sub-distributor of such distributor; or
    (iv)    they are so associated that they have interest, directly or indirectly, in the business of each other.
    Explanation - In this clause -
    (i)      “Inter-connected undertakings” shall have the meaning assigned to it in clause (g) of Section 2 of the Monopolies and Restrictive Trade Practices Act, 1969 (64 of 1969); and
    (ii)     “relative “ shall have the meaning assigned to it in clause (41) of Section 2 of the Companies Act, 1956 (1 of 1956).”

    9. Section 4(1)(b) will govern valuation in this case, the manner in which this valuation is to be done is prescribed under the Valuation Rules. Neither the assessee nor the Revenue has harped on Rules 4 to 7 of these Rules. In the Revenue’s appeal, the appellant wants to have the goods valued under Rule 8. The adjudicating Commissioner has held that the subject goods should be valued in terms of Rules 8, 9 and 10 of the Valuation Rules. These Rules are extracted as below :

    “RULE 8 : Where the excisable goods are not sold by the assessee but are used for consumption by him or on his behalf in the production or manufacture of other articles, the value shall be (one hundred and ten per cent) of the cost of production or manufacture of such goods.
    RULE 9 : When the assessee so arranges that the excisable goods are not sold by an assessee except to or through a person who is related in the manner specified in either of sub-clause (ii), (iii) or (iv) of Clause (b) of sub-section (3) of Section 4 of the Act, the value of the goods shall be the normal transaction value at which these are sold by the related person at the time of removal, to buyers (not being related person), who sells such goods in retail :
    Provided that in a case where the related person does not sell the goods but uses or consumes such goods in the production or manufacture of articles, the value shall be determined in the manner specified in Rule 8.
    RULE 10 : When the assessee so arranges that the excisable goods are not sold by him except to or through an inter-connected undertaking, the value of goods shall be determined in the following manner, namely :-
    (a)     If the undertakings are so connected that they are also related in terms of sub-clause (ii), (iii) or (iv) of Clause (b) of sub-section (3) of Section 4 of the Act or the buyer is a holding company or subsidiary company of the assessee, then the value shall be determined in the manner prescribed in Rule 9.
    Explanation - In this clause “holding company” and “subsidiary company” shall have the same meanings as in the Companies Act, 1956 (1 of 1956).
    (b)     In any other case, the value shall be determined as if they are not related persons for the purpose of sub-section (1) of Section 4.”

    10. The basic issue was that M/s. STBM has been held as a dummy unit but no show cause notice was issued to them. We find that the Commissioner in this regard held that M/s. STBM was a dummy unit only in the sense that there was no employee in M/s. STBM that all works of M/s. STBM were done by the employees of M/s. TBM and the goods never reached the premises of M/s. STBM. Therefore he found that M/s. STBM is a company on paper only and held that M/s. STBM is a non-existent company. It was not required therefore to issue a show cause notice to M/s. STBM.

    11. We proceed further. As noted above the major question is whether M/s. STBM is a dummy unit or not. The Shri K. Sreedharan, learned counsel for appellant submitted certain documents in the form of various judgments like income-tax returns, memorandum and articles of association, annual returns, etc., to demonstrate the independent existence of M/s. STBM. It was appellant’s contention that they have reimbursed the expenses incurred for them by the appellants by way of debit notes paid the job charges, has sold Cell Pack to the appellants and received payments there against and all such transactions have been recorded in the books of account of both the companies. They have also contended that there is nothing unusual in employees of a particular company handling jobs of various group companies without additional remuneration. They were relying upon the following judgments of the Hon’ble Supreme Court and Tribunal ;

    (i)      Industrial Supplies and Services v. CCE [ (Tri.-Del.).]
    (ii)    Thiagraja Engineering Enterprise v. CCE [ (S.C.).]
    (iii)   Box and Carton India (P) Ltd. v. CCE [ (Tri.-Del.).]

    12. It was submitted by the appellant that M/s. Sysmex Transasia Bio-Medicals Ltd. was found as a joint venture company vide an agreement dated 31-3-1998 entered into between M/s. Toa Medical Electronics Company Ltd., Japan (now known as M/s. Sysmex Corporation, Japan) and the appellants herein that the former holding 51% shares and the balance 49% equated being held by the appellants. Later in pursuance of decentralization of their world wide business the shares held by M/s. Toa Medical Electronics Company Ltd. was transferred by them in favour of their subsidiary company known as M/s. Sysmex Singapore Pvt. Ltd. in pursuance of an agreement dated 18-9-1998. M/s. Sysmex Transasia Bio-Medicals Ltd. was found an incorrect as Pvt. Ltd. Company on 23-7-1998 with certificate of incorporation No. 115943 of 1998 issued by the Registrar of Companies, Maharashtra State. Thereafter they were regularly filing annual returns as required under Section 159 of Companies Act, 1956 with the Registrar of Companies. They were also filing income-tax returns and holding a permanent account No. AADCS 1551J. As per the terms of the joint venture agreement and also in terms of the provisions of Section 285 of the Companies Act, 1965, M/s. Sysmex have been holding the meetings of their Board of Directors at least once in a quarter and the minutes of such meetings were recorded in the prescribed minutes register. They also submitted that M/s. Sysmex Transasia Bio-Medicals Ltd. had applied to the Reserve Bank of India for remitting the payment towards royalty on sales to M/s. Sysmex Corporation and the same was granted by the Reserve Bank of India vide their letter dated 8-7-1998 and subsequent communication dated 12-4-2001. The following documents were submitted by the appellants.

    1.      Joint Venture Agreement dated 31-3-1998.
    2.      Agreement dated 18-9-1998 between M/s. Sysmex Corporation, Japan and M/s. Sysmex Singapore Pvt. Ltd.
    3.      Memorandum and Articles of Association of M/s. Sysmex Transasia.
    4.      Annual returns filed by M/s. Sysmex for the years 1998-99, 1999-2000, 2000-01, 2002-03, 2003-04 & receipt of filing fees in respect of annual return for 2001-02
    5.      Income Tax Returns (acknowledgement) filed by M/s. Sysmex for the Asst. Years 1999-2000 to 2004-05.
    6.      Minutes of 22 Board Meetings held by M/s. Sysmex during the period from Sept. 1998 to March, 2004.
    7.      Letters dated 8-7-1998 (rnney/6-l) and 12-4-2001 respectively of RBI.

    13. A perusal of these documents show that such returns, agreements and memorandum of articles are seemingly genuine and admitted by the concerned authorities. The learned counsel further submitted the documents as follows;

    1.      Business Centre Agreement dated 23-7-1998;
    2.      Business Centre Agreement dated 1-4-2001;
    3.      Certificate of Employment Contract dated 1-1-2001 in respect of Shri Hiroki Yamada;
    4.      Service Memorandum dated 1-9-2001; and
    5.      Specimen Debit Notes raised by the appellants on M/s. Sysmex Transasia for recovery of expenses.

    14. It is seen that for the purpose of manufacture of Cell Pack on job work basis by the appellants M/s. Sysmex Transasia Bio-Medicals Ltd. which applied and obtained a loan licence No. DD162 issued by the Drugs Licensing Authority, Daman. The copies of the subject licence and manufacturing agreement dated 23-7-1998 between the appellants and M/s. Sysmex Transasia Bio-Medicals Ltd. and the certificate dated 7-6-2003 for renewal of loan licence were also produced. The appellants also submitted that M/s. Sysmex Transasia Bio-Medicals Ltd. were importing the basic raw material namely Cell Pack from M/s. Sysmex Corporation (Japan/Singapore) after clearing the same on payment of appropriate customs duty, the same was being supplied under cover of challans or such documents to the appellants for the manufacture of Cell Pack on job work basis. On completion of the manufacture of Cell Pack the appellants were returning the same to M/s. Sysmex Transasia Bio-Medicals Ltd. under the cover of central excise invoice. The duty was required to be paid on the basis of cost of raw material + cost of manufacture + manufacturing profit in the light of the principle of law laid dovm by Hon’ble Supreme Court in Ujagar Prints’ case and they were paying duty on the basis of the selling price i.e. Rs. 850/- per unit charged by M/s. Sysmex Transasia Bio-Medicals Ltd. and preparing the central excise invoice accordingly. The appellants were ultimately selling the goods from the godown at the prices ranging from Rs. 2100/- per unit to Rs. 3100/- per unit. They were filing regular monthly returns and maintaining records prescribed under the law. The facts being so and supported by several documents as a proof, it can be safely concluded that M/s. STBM cannot be a dummy unit as argued by the Revenue.

    15. It is also a fact that during adjudication or later the genuineness of the the documents submitted by the appellants were not challenged. There is nothing on record to show that Cell Pack manufactured on job work out of the raw material supplied by M/s. Sysmex Transasia Bio-Medicals Ltd. were not dispatched to the premises Gala No. 5, Prithvi, Industrial Complex, Somnath, Nani, Daman. The copies of transport receipt showing excise invoices were produced by the appellants and they had paid transportation charges to the transporters. The argument of the appellants that they were doing the marketing of Cell Pack as they were already in the business of selling not only diagnostic reagents and also imported Cell Counters. Physical movement of Cell Pack to and from M/s. Sysmex Transasia Bio-Medicals Ltd. was neither necessary nor envisaged nor obligatory in law gain credence. It could only be termed as a choice of business practice by the concerned parties.

    16. In view of the above facts and circumstances, the Hon’ble Supreme Court of India’s judgment in the case of Union of India & Ors. v. Atic Industries Ltd. - (S.C.) becomes very significant. The relevant portion is quoted as below;

    “5. The second ground on which the assessee assailed the validity of the demand made by the Assistant Collector for differential duty related to the applicability of the definition of “related person” in clause (c) of sub-section (4) of Section 4 of the amended Act. The Assistant Collector took the view that the assessee on the one hand and Atul Products Limited and Crescent Dyes and Chemicals Limited on the other were related persons within the meaning of the first part of the definition of the term “related person” and the assessable value of the dyes manufactured by the assessee for the purpose of excise duty was, therefore, liable to be determined with reference to the price at which the dyes were ordinarily sold by Atul Products Limited and Crescent Dyes and Chemicals Limited. This view taken by the Assistant Collector was set aside by the High Court on the ground that the assessee on the one hand and Atul Products Limited and Crescent Dyes and Chemicals Limited on the other were not “related persons” and the wholesale cash price charged by the assessee to Atul Products Limited and Crescent Dyes and Chemicals Limited and not the price at which the latter sold the dyes to the dealers or the consumers, represented the true measure of the value of the dyes for the purpose of chargeability to excise duty. This conclusion reached by the High Court was assailed before us by the learned Attorney General appearing on behalf of the Revenue. He fairly conceded that the only part of the definition of “related person “ in clause (c) of sub-section (4) of Section 4 on which he could reply was the first part which defines “related person” to mean “a person who is so associated with the assessee that they have interest directly or indirectly in the business of each other”. The second part of the definition which adds an inclusive clause was admittedly not applicable, because neither Atul Products Limited nor Crescent Dyes and Chemicals Limited was a holding company or a subsidiary company nor was either of them a relative of the assessee, so as to fall within the second part of the definition. But we do not think that even the limited contention urged by the learned Attorney General on behalf of the Revenue based on the first part of the definition can succeed. What the first part of the definition requires is that the person who is sought to be branded as a “related person “ must be a person who is so associated with the assessee that they have interest, directly or indirectly, in the business of each other. It is not enough that the assessee has an interest, direct or indirect, in the business of the person alleged to be a related person nor is it enough that the person alleged to be a related person has an interest, direct or indirect, in the business of the assessee. It is essential to attract the applicability of the first part of the definition that the assessee and the person alleged to be a related person must have interest, direct or indirect, in the business of each other. Each of them must have a direct or indirect interest in the business of the other. The equality and degree of interest which each has in the business of the other may be different; the interest of one in the business of the other may be direct, while the interest of the latter in the business of the former may be indirect. That would not make any difference, so long as each has got some interest, direct or indirect, in the business of the other. Now, in the present case, Atul Products Limited has undoubtedly interest in the business of the assessee, since Atul Products Limited holds 50 per cent of the share capital of the assessee and has interest as share holder in the business carried on by the assessee. But it is not possible to say that the assessee has any interest in the business of Atul Products Limited. There are two points of view from which the relationship between the assessee and Atul Products Limited may be considered. First, it may be noted that Atul Products Limited is a shareholder of the assessee to the extent of 50 per cent of the share capital. But we fail to see how it can be said that a limited company has any interest, direct or indirect, in the business carried on by one of its shareholders, even though the shareholding of such shareholder may be 50 per cent. Secondly, Atul Products Limited is a wholesale buyer of the dyes manufactured by the assessee but even then, since the transactions between them are as principal to principal, it is difficult to appreciate how the assessee could be said by virtue of that circumstance to have any interest, direct or indirect, in the business of Atul Products Limited. Atul Products Limited buys dyes from the assessee in wholesale on principal to principal basis and then sells such dyes in the market. The assessee is not concerned whether Atul Products Limited sells or does not sell the dyes purchased by it from the assessee nor is it concerned whether Atul Products Limited sells such dyes at a profit or at a loss. It is impossible to contend that the assessee has any direct or indirect interest in the business of a wholesale dealer who purchases dyes from it on principal to principal basis. The same position obtains in regard to Crescent Dyes and Chemicals Limited. Perhaps the position in reard to Crescent Dyes and Chemicals Limited is much stronger than that in regard to Atul Products Limited. Crescent Dyes and Chemicals Limited is not even a shareholder of the assessee and it has, therefore, no interest direct or indirect in the business of the assessee. It is Imperial Chemical Industries Limited, London which holds 50 per cent of the share capital of the assessee and this foreign company also holds 40 per cent of the share capital of Crescent Chemicals and Dyes Limited. Imperial Chemicals Industries Limited, London would admittedly have an interest in the business of the assessee in its capacity as a shareholder, but how can Crescent Dyes and Chemicals Limited of which 40 per cent of the shares are held by Imperial Chemical Industries Limited, London which in its turn is a shareholder of the assessee, can be said to have any interest, direct or indirect, in the business of the assessee. Equally the assessee has no interest direct or indirect in the business of Crescent Dyes and Chemicals Limited, which is just a wholesale dealer purchasing dyes from the assessee in wholesale on principal to principal basis. It is obvious that for the same reasons which have prevailed with us while discussing the case of Atul Products Limited, the assessee has no direct or indirect interest in the business of Crescent Dyes and Chemicals Limited. The first part of the definition of related person in clause (c) of sub-section (4) of Section 4 of the amended Act is, therefore, clearly not satisfied both in relation to Atul Products Limited as also in relation to Crescent Dyes and Chemicals Limited and neither of them can be said to be a “related person” vis-a-vis the assessee within the meaning of the definition of that term in clause (c) of sub-section (4) of Section 4 of the amended Act. We, therefore, affirm the view taken by the High Court and hold that the assessable value of the dyes manufactured by the assessee cannot be determined with reference to the selling price charged by Atul Products Limited and Crescent Dyes and Chemicals Limited to their purchasers but must be determined on the basis of the wholesale cash price charged by the assessee to Atul Products Limited and Crescent Dyes and Chemicals Limited. The demand made by the Assistant Collector for differential duty must, therefore, be held to be rightly quashed by the High Court.”
    This being the crucial issue in this case, we respectfully follow the judgment of the Hon’ble Supreme Court.

    17. It is a well settled law that for purpose of Section 4 concerned would be taken to be the related person if there is a reciprocity of interest between the assessee and such allegedly related person. The Hon’ble Supreme Court in the case of Commissioner of Customs, Kolkata v. Initiating Explosives System (I) Ltd. - (S.C.) very succinctly observed, The burden to prove that the goods in question were undervalued by the respondent lies on the Revenue which the Revenue has failed to discharge.

    Another issue raised by the Revenue was regarding the clearance of diagnostic reagents and demokits without payment of duty. The contention of the Revenue was that auto analysers are exempted from duty but there is no notification to this effect that diagnostic reagents used with auto analysers are also exempted. The contention of the appellants is that diagnostic reagents were meant for the use only with instruments namely auto analysers sold by them which are exempted from payment of duty. Diagnostic reagents are cleared either by way of free replenishments against the coupons provided to the customers at the time of purchase of the instruments or supplied as free of cost to them which should be considered as a discount in kind and therefore no duty is payable as per provisions of Section 4. They submitted that no payments were collected or received by the appellants there against and invoices were issued only for accounting purpose. Regarding the demokits it is seen that they are not marketable and again supplied along with the instruments to the customers for purpose as demonstration and these kits are distinguishable from the normal kits of diagnostic reagents cleared by the appellants. The cost of such demokits as stated by the appellants is included in the sale price of the instruments which are exempted from payment of duty. In the absence of any evidence to prove otherwise the contention of the appellant seems to be acceptable.

    18. The Revenue has raised the point of demanding duty on packing and forwarding charges. It was the contention of the appellant that as per provisions of Section 4 read with Rules 5 and 7 of Valuation Rules when the goods are sold at the factory gate but the goods are transferred to a depot or such other place from where the delivery is made to the customers’ premises the assessable value would be the transaction value without the addition of case of transportation. Rule 5 of the Central Excise Valuation Rules reads as follows :

    “Where any excisable goods are sold in the circumstances specified in clause (a) of sub-section (1) of Section 4 of the Act except the circumstances in which the excisable goods are sold for delivery at o place other than the place of removal, then the value of such excisable goods shall be deemed to be the transaction value, excluding the cost of transportation from the place of removal upto the place of delivery of such excisable goods.
    Explanation 1. - “Cost of transportation” includes,-
    (i)      the actual cost of transportation; and
    (ii)     in case where freight is averaged, the cost of transportation calculated in accordance with generally accepted principles of costing.”

    19. However, the Revenue admits that the appellants are eligible for deduction of actual freight from their godown to the premises of customers. The decision of the Hon’ble Supreme Court in the case of Baroda Electric Meter - (S.C.) become relevant.

    20. It was the case of Revenue that the appellant was not eligible for SSI exemption for the year 2001-2002 on the ground that clearance value has exceeded Rs. 3 crores in the previous year. The clearance value exceeded because it was arrived at by adopting the value at which the appellants have sold their packs from depot instead of adopting the value on which they sold to M/s. STBM. The value of clearances of diagnostic reagents and demokits as well as the value of packing charges and forwarding charges have also been added to the value of clearance. However, the contention of the appellant is that they have not collected any duty from their customers in respect of clearances made by them by availing the benefit of SSI exemption. The appellant’s contention was that value of clearances worked out by Revenue includes packing and forwarding charges allegedly recovered in excess from customers, clearances of demokits without payment of duty and overvaluation of Cell Pack. They asserted that they had not collected any amount by way of excise duty from their customers in respect of clearances made by them during the relevant period. They argued that this will be clear from the excise invoice and the corresponding commercial invoice.

    21. In view of the above discussions, we are of opinion that unless it is proved otherwise, the value of clearances as contended by the appellants has to be considered. Since there is no evidence to prove otherwise the contention of the Revenue remains unsubstantiated and the SSI exemption is rightly available to the appellants.

    22. With regard to the allegation that the extended period is available because of suppression/misstatement of facts with an intend to evade payment of duty the appellant argued that the allegations are baseless and untenable in law. They submitted that the production and clearance of diagnostic reagents demokits were duly recorded by them in their records and had been subjected to audit/verification. Regarding freight charges also it was submitted that they were under the bona fide belief that the excess of actual amount paid towards the freight was not liable to be included for purpose of determination of assessable value in view of the principles of law laid down in the Acts and Rules. It was the opinion of the appellant that the department was in full knowledge of the activities while they were initiating proceedings by way of issue of show cause notice on different grounds in the past during the relevant time. In support of their submissions the appellants relied upon the following judgments ;

    1.      Pushpam Pharmaceuticals Co. v. CCE, Bombay - (S.C.).
    2.      Cosmic Dye Chemical v. CCE, Bombay - (S.C.)
    3.      Collector v. Chemphar Drugs & Liniments - (S.C.).
    4.      Padmini Products v. Collector - (S.C.)
    5.      ATE Enterprises Ltd. v. CCE - (Tri.-Del.)
    6.      MEK Slotted Angles (India) Ltd. v. CCE - (Tri.-Mum.)

    23. Facts being so, it was argued by the appellant that as per various reasons submitted above, imposition of penalty under Section 11AC is not sustainable. Interest therefore also not sustainable under Section 11AB.

    24. On going through the facts as above and various judgments quoted, we cannot persuade our mind that there was suppression or misstatement of facts with an intention to evade payment of duty nor there was any evidence either documentary or otherwise comingforth to support the case of Revenue.

    25. We have sailed through the various contentions of Revenue and appellants’ documents and evidences before us and various legal pronouncements. We are of opinion that disposal of cases by blindly placing reliance on some decisions or some evidences may not be proper.

    26. The following words of Lord Denning in the matter of applying precedents have become locus classicus :

    “Each case depends on its own facts and a close similarity between one case and another is not enough because even a single significant detail may alter the entire aspect, in deciding such cases, one should avoid the temptation to decide cases (as said by Cordozo) by matching the colour of one case against the colour of another. To decide therefore, on which side of the line a case falls, the broad resemblance to another case is not at all decisive.’’
    ****       ***          ***
    “Precedent should be followed only so far as it marks the path of justice, but you must cut the dead wood and trim off the side branches else you will find yourself lost in thickets and branches. My plea is to keep the path to justice clear of obstructions which could impede it.”

    27. We strongly believe that disposal of each case depends on the merits, evidences, principles of law and requires a proper examination to arrive at a conclusion case-wise. The case of the appellants we find is sustainable.

    28. Accordingly, we allow the appeals filed by M/s. Transasia Bio-Medicals Ltd. and others and set aside the order of the Commissioner of Central Excise & Customs, Daman.

    (Pronounced in Court on 17-1-2012)

    Use AI to get other relevant cases.

    Comments

    Transasia Bio-Medicals Ltd. v. Commissioner of C. Ex., Daman
    (Jan 17, 2012)